Quality of evidence: B+
Prevalence and Impact of Diabetes Among People Infected With SARS-CoV-2
Authors: Fadini GP et al.
Journal: The Journal of Endocrinological Investigation
Objectives: Assess the prevalence of diabetes and its impact on ill patients' faith as of late march 2020
Strength of evidence: Moderate (meta-analysis, large population, only hospitalized patients, validation by rt-qPCR)
Methods/publication type:
Meta-analysis/letter to the editor
12 studies, 2108 patients validated by RT-qPCR
Average age 49.6
Highlights :
No higher risk of contracting the disease in Italy and China (same or lower prevalence among patients than among the general population and population matched by age)
Only hospitalized patients, diabetes treatments might also explain these results
Higher risk of complications (RR = 2.26)
In Italy, higher fatality rate in diabetics with death RR = 1.75
Comentarios